We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.53B
AUM Growth
+$430M
Cap. Flow
+$424M
Cap. Flow %
11.99%
Top 10 Hldgs %
19.3%
Holding
632
New
232
Increased
83
Reduced
96
Closed
207

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$111M
2
EA icon
Electronic Arts
EA
+$45.7M
3
AKAM icon
Akamai
AKAM
+$45.1M
4
ALIT icon
Alight
ALIT
+$40.9M
5
MRK icon
Merck
MRK
+$39.9M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$62.7M
2
BBY icon
Best Buy
BBY
+$59.6M
3
TKO icon
TKO Group
TKO
+$54.5M
4
HAS icon
Hasbro
HAS
+$47.1M
5
NSC icon
Norfolk Southern
NSC
+$46.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.97%
2 Technology 13.31%
3 Industrials 12.3%
4 Healthcare 9.88%
5 Communication Services 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JANX icon
401
Janux Therapeutics
JANX
$925M
$226K 0.01%
+5,400
New +$254K
SGI
402
Somnigroup International
SGI
$13.7B
$221K 0.01%
+4,666
New +$236K
TEVA icon
403
Teva Pharmaceuticals
TEVA
$40.8B
$219K 0.01%
13,500
-13,500
-50% -$208K
TRUP icon
404
CALL
Trupanion
TRUP
$1.07B
$218K 0.01%
+7,400
New +$196K
PCVX icon
405
Vaxcyte
PCVX
$7.81B
$204K 0.01%
+2,700
New +$184K
GERN icon
406
Geron
GERN
$828M
$172K ﹤0.01%
40,500
-220,897
-85% -$861K
SBH icon
407
Sally Beauty Holdings
SBH
$1.43B
$161K ﹤0.01%
+15,047
New +$165K
LRMR icon
408
Larimar Therapeutics
LRMR
$397M
$143K ﹤0.01%
19,705
-8,295
-30% -$63.5K
AAL icon
409
American Airlines Group
AAL
$10.1B
$138K ﹤0.01%
+12,209
New +$160K
NPWR icon
410
CALL
NET Power
NPWR
$126M
$118K ﹤0.01%
51,706
BTDR icon
411
Bitdeer Technologies
BTDR
$2.56B
$115K ﹤0.01%
+11,250
New +$77.1K
ACHV icon
412
Achieve Life Sciences
ACHV
$659M
$115K ﹤0.01%
24,548
VERU icon
413
Veru
VERU
$36M
$114K ﹤0.01%
13,500
-124,545
-90% -$1.44M
COMP icon
414
CALL
Compass
COMP
$8.51B
$96.1K ﹤0.01%
26,700
+4,200
+19% +$15.4K
WW
415
DELISTED
WW International
WW
$77K ﹤0.01%
65,792
+48,692
+285% +$81K
CALC icon
416
CalciMedica
CALC
$15.8M
$74.8K ﹤0.01%
+18,900
New +$95.2K
IMTX icon
417
CALL
Immatics
IMTX
$1.18B
$72.2K ﹤0.01%
26,984
FUBO icon
418
FuboTV Inc
FUBO
$261M
$62.4K ﹤0.01%
+4,193
New +$67.1K
SIRI icon
419
CALL
SiriusXM
SIRI
$9.97B
$58K ﹤0.01%
+2,050
New +$61.2K
SVRA icon
420
Savara
SVRA
$1.12B
$52.4K ﹤0.01%
+13,000
New +$57.8K
RDFN
421
CALL
DELISTED
Redfin
RDFN
$45.1K ﹤0.01%
+7,500
New +$46.9K
LZM.WS icon
422
CALL
Lifezone Metals Ltd Warrants
LZM.WS
$19.8M
$34.5K ﹤0.01%
75,000
AVDL
423
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$32.3K ﹤0.01%
+2,300
New +$37.5K
TXMD icon
424
TherapeuticsMD
TXMD
$23.5M
$21.8K ﹤0.01%
13,562
ADV icon
425
CALL
Advantage Solutions
ADV
$522M
$2.19K ﹤0.01%
2,395

Similar funds

J. Goldman & Co's Q2 2024 Portfolio in Review

As of Q2 2024, J. Goldman & Co held 632 positions worth $3.53B, up 14% from $3.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

J. Goldman & Co deployed $424M of net new capital in Q2 2024, opening 232 new positions and adding to 83 existing holdings. Its largest new stake was Constellation Brands: 431,859 shares worth $111M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Texas Instruments, an estimated $30M trimmed.

  • J. Goldman & Co's largest Q2 2024 buy was Constellation Brands: 431,859 shares worth $111M.
  • J. Goldman & Co added most to Merck in Q2 2024, an estimated $39.9M increase.
  • J. Goldman & Co's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $30M.
  • J. Goldman & Co fully exited Sherwin-Williams in Q2 2024, selling an estimated $62.7M.
  • J. Goldman & Co's ten largest holdings make up 19% of its $3.53B portfolio in Q2 2024.
  • J. Goldman & Co opened 232 new positions and closed 207 in Q2 2024.
  • J. Goldman & Co's portfolio value rose 14% quarter-over-quarter to $3.53B.

Based on J. Goldman & Co's 13F filing for Q2 2024, filed 14 Aug 2024.